Thrombotic microangiopathy under an effective treatment with gemcitabine;Thrombotische Mikroangiopathie unter einer effektiven Therapie mit Gemcitabin

Zeitschrift fur Gastroenterologie

Volumn 47, Issue 3, 2009, Pages 288-291

  Finkenwirth, P ^a   Schick, D ^a   Horger, M S ^a   Fend, F ^a   Lauer, U M ^a   Gregor, M ^a   Bitzer, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Gastroenteropancreatic tumours; Gemcitabine; Microangiopathy

Indexed keywords

CREATININE; GEMCITABINE; LACTATE DEHYDROGENASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AGED; ANEMIA; ANURIA; ARTICLE; BLOOD SMEAR; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DYSPNEA; ENZYME ACTIVITY; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; MALE; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; PALLIATIVE THERAPY; PANCREAS CARCINOMA; PATHOPHYSIOLOGY; PLASMAPHERESIS; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, LARGE CELL; DEOXYCYTIDINE; ERYTHROCYTES; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LIVER NEOPLASMS; MALE; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME;

EID: 64349119978     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027625     Document Type: Article

References (9)

1. Fung MC, Stomiolo AM, Nguyen B et al. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer 1999; 85:2023-2032
2. Humphreys BD, Sharman JP, Henderson JM et al. Gemcitabine- associated thrombotic microangiopathy. Cancer 2004; 100: 2664-2670
3. Müller S, Schütt P, Bojko P et al. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol 2005; 84: 110-114
4. Rock CA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325:393-397
5. Bell WR, Braine HC, Ness PM et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991; 325: 398-403
6. Ahmad A, Aggarwal A, Sharma D et al. Rituximab for the treatment of refractory/relapsing thrombotic thrombocytopenic purpura (UP). Am J Hematol 2004; 77: 171-176
7. Reddy PS, Deauna-Limayo D, Cook JD et al. Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura. Ann Hematol 2005; 84:232-235
8. Koulova L, Alexandrescu D, Dutcher JP et al. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (UP): report of three cases. Am J Hematol 2005;78:49-54
9. Rüfer A, Brodmann D, Gregor M et al. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. Swiss Med Wkly 2007; 137: 518-524